Journal article · 2022 · Open access
Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form
British Journal of Dermatology, 187(4), 588–589 · Published 1 October 2022 · DOI 10.1111/bjd.21593
In brief
“Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form” is a 2022 journal article by Christine Blome and 9 co-authors, published in British Journal of Dermatology. OpenAlex counts 4 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at British Journal of Dermatology.
- Citations
- 4
- Most cited in
- 2024 (2)
- Field-weighted impact
- 0.34
- References
- 8
- Authors
- 10
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Blome, C., von Stülpnagel, C. C., Augustin, M., Mrowietz, U., Reich, K., Muehlan, H., Kirsten, N., Langenbruch, A. K., Sorbe, C., & Klein, T. M. (2022). Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form. British Journal of Dermatology, 187(4), 588–589. https://doi.org/10.1111/bjd.21593
MLA 9
Blome, Christine, et al. “Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form.” British Journal of Dermatology, vol. 187, no. 4, 2022, pp. 588–589. https://doi.org/10.1111/bjd.21593.
Chicago
Blome, Christine, Catharina C. von Stülpnagel, Matthias Augustin, Ulrich Mrowietz, Kristian Reich, Holger Muehlan, Natalia Kirsten, Anna Katharina Langenbruch, Christina Sorbe, and Toni Maria Klein. 2022. “Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form.” British Journal of Dermatology 187 (4): 588–589. https://doi.org/10.1111/bjd.21593.
Harvard
Blome, C. et al. (2022) ‘Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form’, British Journal of Dermatology, 187(4), pp. 588–589. doi:10.1111/bjd.21593.
IEEE
C. Blome et al., “Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form,” British Journal of Dermatology, vol. 187, no. 4, pp. 588–589, 2022, doi: 10.1111/bjd.21593.
BibTeX
@article{blome2022measuring,
title = {{Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form}},
author = {Blome, Christine and von Stülpnagel, Catharina C. and Augustin, Matthias and Mrowietz, Ulrich and Reich, Kristian and Muehlan, Holger and Kirsten, Natalia and Langenbruch, Anna Katharina and Sorbe, Christina and Klein, Toni Maria},
journal = {British Journal of Dermatology},
year = {2022},
volume = {187},
number = {4},
pages = {588--589},
doi = {10.1111/bjd.21593},
url = {https://doi.org/10.1111/bjd.21593}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 2 | |
| 2025 | 1 |
Its field-weighted citation impact is 0.34: it has been cited 0.34 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- psoriasis
- Patient Benefit Index
- short-form questionnaire
- questionnaire development
- questionnaire validation
- treatment outcomes
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Blome, C., von Stülpnagel, C. C., Augustin, M., Mrowietz, U., Reich, K., Muehlan, H., Kirsten, N., Langenbruch, A. K., Sorbe, C., & Klein, T. M. (2022). Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form. British Journal of Dermatology, 187(4), 588–589. https://doi.org/10.1111/bjd.21593
How many times has this paper been cited?
4 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at British Journal of Dermatology: sign in and open the full text from this page.
Who wrote this paper?
Christine Blome, Catharina C. von Stülpnagel, Matthias Augustin, Ulrich Mrowietz, Kristian Reich, Holger Muehlan, Natalia Kirsten, Anna Katharina Langenbruch, Christina Sorbe, Toni Maria Klein.
What is the DOI of this paper?
10.1111/bjd.21593, permanently at https://doi.org/10.1111/bjd.21593. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.